Xylazine-Associated Wounds: Considerations for Antimicrobial Stewardship and Wound Care
Please join us for a live, CME-accredited webinar on Tuesday, Feb. 25, from noon to 1 p.m. that will educate providers on the important topic of xylazine associated wounds.
At the end of this learning session, you will be able to:
- Discuss antimicrobial stewardship program adaptations for people who inject drugs.
- Identify outpatient antimicrobial treatment considerations for xylazine-associated wounds.
- Review pharmacology and treatment of xylazine toxicity and withdrawal.
Presenters:
- Michael Lynch, MD, FACMT, UPMC Health Plan Quality and Substance Use Disorder Services Senior Medical Director; Director, UPMC Medical Toxicology Telemedicine Bridge Clinic; Associate Professor, Division of Medical Toxicology, Department of Emergency Medicine, University of Pittsburgh School of Medicine
Amanda Hoyer, MPH,
- Epidemiology Research Associate, Division of Healthcare Associated Infection Prevention, Bureau of Epidemiology, Pennsylvania Department of Health
Register now. This webinar will be recorded.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team. The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Provider is responsible for verifying CME eligibility.